{
    "symbol": "RVNC",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-28 23:26:06",
    "content": "   During this conference call, management will make forward-looking statements, including statements related to 2023 guidance, cash flow breakeven, and future revenue and expenses, our value creation on growth potential, the efficacy and duration of DAXXIFY, our ability to draw on our debt, our regulatory submissions and approvals, our entry into the therapeutics market, our commercial success, consumer preferences and behavior that benefits to us practices and consumers of our products and services, consumer outcomes, the supply of manufacturing of DAXXIFY, sales team growth and our strategy, planned operations, services strategy and commercialization plans and timing."
}